問卷
Log In
繁中 EN
TPIDB
TPIDB Outstanding PI
TPIDB > Search Result

Search Result

篩選

Developmental Phase

  • Phase I

  • Phase I/II

  • Phase II

  • Phase II/III

  • Phase III

  • Phase IV

  • Others

Trial Status

  • Not yet recruiting

  • Active

  • Completed

Recruitment Status

  • Not yet recruiting

  • Recruiting

  • Completed

  • Terminated

  • Stop recruiting

  • Suspended

  • Study ended

Trial scale

  • Multi-Regional Multi-Center

  • Taiwan Multiple Center

  • Taiwan Single Center

The expected start time interval of the test

-

Trial Applicant

  • Hospital/Foundation

  • Pharmaceutical/Biopharmaceutical company

  • Contract Research Organization

Important Roles

  • Asia Regional PI

  • Taiwan National PI

  • Chairman/Global PI

  • Steering Committee

  • Advisory board

  • None

Audit by Sponsors/CRO

  • Sponsors

  • CRO

  • None

Investigator-initiated trial(IIT)

  • Yes

Filters

陳力源

Recruiting

List

4Cases

2022-07-01 - 2024-09-20

Phase III

Completed

  • Condition/Disease

  • Test Drug

Participate Sites
16Sites

Not yet recruiting3Sites

Recruiting11Sites

Terminated2Sites

2021-05-31 - 2027-12-31

Phase II/III

Active

  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting5Sites

Terminated1Sites

2021-05-31 - 2027-12-31

Phase II/III

AN ADAPTIVE PHASE II/III, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, TWO-PART, DOSE-FINDING, MULTI-CENTER STUDY OF THE SAFETY AND EFFICACY OF NABEN® (SODIUM BENZOATE), A D-AMINO ACID OXIDASE INHIBITOR, AS AN ADD-ON THERAPY WITH CLOZAPINE, FOR RESIDUAL SYMPTOMS OF REFRACTORY SCHIZOPHRENIA IN ADULTS

  • Condition/Disease

    Residual Symptoms of Refractory Schizophrenia in Adults

  • Test Drug

    NaBenR

Participate Sites
5Sites

Recruiting5Sites

2021-05-31 - 2023-11-29

Phase II/III

AN ADAPTIVE PHASE II/III, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, TWO-PART, DOSE-FINDING, MULTI-CENTER STUDY OF THE SAFETY AND EFFICACY OF NABEN® (SODIUM BENZOATE), A D-AMINO ACID OXIDASE INHIBITOR, AS AN ADD-ON THERAPY WITH CLOZAPINE, FOR RESIDUAL SYMPTOMS OF REFRACTORY SCHIZOPHRENIA IN ADULTS

  • Condition/Disease

    Residual Symptoms of Refractory Schizophrenia in Adults

  • Test Drug

    NaBenR

Participate Sites
6Sites

Recruiting6Sites

聯絡我們

台灣臨床試驗主持人資料庫 TPIDB

All Contents Copyright 2020 台灣臨床試驗主持人資料庫TPIDB